News

Infasurf (calfactant) intratracheal suspension decreases the incidence of respiratory distress syndrome (RDS), mortality due to RDS, and air leaks associated with RDS. “We are pleased to add Infasurf

In January 2004, Myogen announced the initiation of patient enrollment in ARIES 1 and 2, two 186-patient trials in pulmonary arterial hypertension (PAH). ARIES-1 is currently being conducted

MedImmune may also receive certain milestone payments and royalties on future development and sales of an investigational vaccine co-developed by MedImmune and GSK for human papillomavirus (HPV), the

Xcyte withdrew its FDA submission of the clinical protocol for a planned phase II/III trial of Xcellerated T-cells in chronic lymphocytic leukemia, after the FDA requested further discussion

The study showed that Oral-lyn administered in a divided dose produces pharmacokinetic and glucodynamic profiles comparable to that produced by injected regular human insulin (administered in a divided

The Alliance for Lupus Research (ALR) is a leading source of private funding for lupus investigations and, since its inception in 1999, has committed more than $30 million

Kyorin and ActivX have been collaborating since May 2002 to discover new drugs for the treatment of type 2 diabetes. The collaboration was expanded in early 2004 to

ANA975 is an oral prodrug of Anadys’ proprietary small molecule compound isatoribine, an agonist of toll-like receptor 7 (TLR7). Results from clinical trials of isatoribine have demonstrated a

Although specific financial terms were not announced, Schering will receive an upfront fee, milestone payments and royalties on sales of any compounds successfully commercialized under the agreement. ADP